The Scientist

» Alzheimer's Disease and disease/medicine

Most Recent

image: Marriages of Opportunity

Marriages of Opportunity

By | February 1, 2016

New ideas for antibody-drug conjugate design

0 Comments

image: The Mycobiome

The Mycobiome

By | February 1, 2016

The largely overlooked resident fungal community plays a critical role in human health and disease.

10 Comments

image: Schizophrenia and the Synapse

Schizophrenia and the Synapse

By | January 27, 2016

Genetic evidence suggests that overactive synaptic pruning drives development of schizophrenia.

5 Comments

image: More Evidence of Alzheimer’s Transmission

More Evidence of Alzheimer’s Transmission

By | January 27, 2016

Examining the brains of seven patients who died of the prion disease called Creutzfeldt–Jakob, researchers find signs of Alzheimer’s pathology. 

1 Comment

image: Another Role for ApoE?

Another Role for ApoE?

By | January 20, 2016

Key Alzheimer’s disease–related protein may be a transcriptional regulator.

3 Comments

image: UCSD Names New Head of Alzheimer’s Study

UCSD Names New Head of Alzheimer’s Study

By | January 18, 2016

The project at the center of the dust up between the University of California, San Diego, and the University of Southern California gets a new leader, as the institutions continue to battle in court.

0 Comments

image: Disease-Linked Genes Questioned

Disease-Linked Genes Questioned

By | January 6, 2016

Many patients with genetic variations linked to cardiac disorders do not exhibit any symptoms, raising concerns about the validity of incidental findings of genetic tests.

0 Comments

image: Updating the Polio Vaccine

Updating the Polio Vaccine

By | January 4, 2016

Researchers develop new attenuated viruses that could support the eradication effort.

1 Comment

image: Pluripotency Bots

Pluripotency Bots

By | January 1, 2016

A tour of efforts to automate the production and differentiation of induced pluripotent stem cells

0 Comments

image: Picking Up the Pace

Picking Up the Pace

By | January 1, 2016

FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS